Scarica l'app Stockscreener
1.11
2.63%
-0.03
Dopo l'orario di chiusura:
2.58
1.47
+132.43%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Pharmacyte Biotech Inc Borsa (PMCB) Ultime notizie
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Up 1.7% – Still a Buy? - Defense World
PharmaCyte Biotech holds annual meeting, elects directors By Investing.com - Investing.com South Africa
PharmaCyte Biotech holds annual meeting, elects directors - Investing.com
PMCB stock touches 52-week low at $1.03 amid market challenges By Investing.com - Investing.com South Africa
PMCB stock touches 52-week low at $1.03 amid market challenges - Investing.com Australia
PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Down 5.3% – Here’s What Happened - Defense World
Short Interest in PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Grows By 82.3% - Defense World
PMCB stock touches 52-week low at $1.38 amid market challenges - Investing.com India
PharmaCyte Biotech Inc. (PMCB) reports earnings - Quartz
PharmaCyte Biotech, Inc. SEC 10-Q Report - TradingView
PharmaCyte Biotech (OTCMKTS:PMCBD) Shares Down 1.1% – Here’s What Happened - Defense World
Contrasting PharmaCyte Biotech (OTCMKTS:PMCBD) & Tarsus Pharmaceuticals (NASDAQ:TARS) - Defense World
PharmaCyte Biotech appoints new accounting firm By Investing.com - Investing.com South Africa
PharmaCyte Biotech appoints new accounting firm - Investing.com
Top Penny Stocks To Watch In February 2025 - Simply Wall St
PharmaCyte Biotech (OTCMKTS:PMCBD) and Tenaya Therapeutics (NASDAQ:TNYA) Head to Head Analysis - The AM Reporter
Head to Head Survey: Tenaya Therapeutics (NASDAQ:TNYA) and PharmaCyte Biotech (OTCMKTS:PMCBD) - Defense World
Pancreatic Cancer Precision Medicine Market Report, 2030 - Grand View Research
Malignant Ascites Treatment Market: Trends, Growth, - openPR
Pancreatic Cancer Treatment Market to Surge to USD 10.2 - GlobeNewswire
PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Up 0.1% – What’s Next? - Defense World
Global Ascites Market Size and Trends, Forecast 2025-2035: Unlocking Key Insights for Strategic Growth – Custom Market Insights - BioSpace
PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Shares Sold by Geode Capital Management LLC - Defense World
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading 1.5% Higher – Time to Buy? - Defense World
PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Up 1.5% – Still a Buy? - Defense World
Comparing Vaxcyte (NASDAQ:PCVX) & PharmaCyte Biotech (OTCMKTS:PMCBD) - Defense World
Financial Comparison: Coeptis Therapeutics (NASDAQ:COEP) & PharmaCyte Biotech (NASDAQ:PMCB) - Defense World
PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2024 - Marketscreener.com
CXApp (NASDAQ:CXAI) & Aware (NASDAQ:AWRE) Financial Contrast - Defense World
Jasper Therapeutics (NASDAQ:JSPR) versus PharmaCyte Biotech (OTCMKTS:PMCBD) Head to Head Comparison - Defense World
Zacks Research Issues Positive Estimate for SRPT Earnings - Defense World
T-Mobile US, Inc. to Present at the Wells Fargo TMT Summit - Business Wire
Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference - Business Wire
PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders - Business Wire
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Announces Completion of Liquidation - Business Wire
HubSpot to Present at the Wells Fargo Technology Conference - Business Wire
MTCH Investors Have Opportunity to Lead Match Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
SUM Investors Have the Opportunity to Join Investigation of Summit Materials, Inc. with the Schall Law Firm - Business Wire
Glancy Prongay & Murray LLP Announces Investigation of Triumph Group, Inc. (TGI) - Business Wire
Glancy Prongay & Murray LLP Announces Investigation of TruBridge, Inc. (f//k/a Computer Programs and Systems, Inc.) (TBRG) - Business Wire
Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference - Business Wire
EMCOR Group, Inc. to Participate at the UBS Global Industrials and Transportation Conference - Business Wire
Rallybio to Provide Update on RLYB116 Program, an Innovative Subcutaneously Injected C5 Inhibitor - Business Wire
Shareholder Alert: Ademi LLP Investigates Whether Summit Materials, Inc. is Obtaining a Fair Price for its Public Shareholders - Business Wire
INNOVID INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Innovid Corp.CTV - Business Wire
Excelerate Energy to Participate at Capital One Securities Energy Conference - Business Wire
Community Health Systems Announces Definitive Agreement to Sell ShorePoint Health System in Florida - Business Wire
Savara Announces New Employment Inducement Grant - Business Wire
Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference - Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX) - Business Wire
Vena Recognized as a Challenger in the 2024 Gartner® Magic Quadrant™ for Financial Planning Software - Business Wire
California American Water Relocates Infrastructure to Facilitate Fort Ord Regional Trail and Greenway Through Del Rey Oaks - Business Wire
0.84%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):